DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.

Author(s): Jahns BG, Stein W, Hilfiker-Kleiner D, Pieske B, Emons G

Affiliation(s): Department of Gynecology and Obstetrics, Georg-August-University, Gottingen, Germany. boriana_jahns@yahoo.com

Publication date & source: 2008-10, Am J Obstet Gynecol., 199(4):e5-6.

Publication type: Case Reports

Peripartum cardiomyopathy (PPCM) is a rare disease of unclear etiology with a frequent poor outcome, despite optimal medical therapy. Recent experimental data implicate a causal role of prolactin. We report a patient with PPCM who responded well to treatment with Bromocriptine in addition to standard therapy of heart failure.

Page last updated: 2009-02-08

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017